Unique ID issued by UMIN | UMIN000025685 |
---|---|
Receipt number | R000027922 |
Scientific Title | Effects of Misatol GL , a heat-concentrated extract from Japanese green apricot, in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis -Multicenter trial- |
Date of disclosure of the study information | 2017/01/15 |
Last modified on | 2020/01/22 16:17:48 |
Effects of Misatol GL , a heat-concentrated extract from Japanese green apricot, in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis -Multicenter trial-
Effects of Japanese apricot extract (Misatol GL) in patients with NAFLD /NASH
Effects of Misatol GL , a heat-concentrated extract from Japanese green apricot, in patients with non-alcoholic fatty liver disease / non-alcoholic steatohepatitis -Multicenter trial-
Effects of Japanese apricot extract (Misatol GL) in patients with NAFLD /NASH
Japan |
NAFLD/NASH
Hepato-biliary-pancreatic medicine |
Others
NO
The aim of this study is to examine the effects of Misatol GL on serum ALT in patients with NAFLD /NASH
Safety,Efficacy
Change in serum ALT
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Food |
Misatol GL twice (6.5g x 2) per day for 8 weeks
Placebo twice (6.5g x 2) per day for 8 weeks
20 | years-old | <= |
75 | years-old | > |
Male and Female
1. Patients with hepatic steatosis is suspected by abdominal US, CT or MRI tests.
2. ALT higher than 60 IU/L
3. Patients who are able to provide written informed consent.
1. Patients who have serious liver disease (decompensated cirrhosis (Child-Pugh B<), liver cancer), whose ALT higher than 300 IU/L, or jaundice.
2. Other chronic liver disease (alcoholic liver disease, virus hepatitis, autoimmune hepatitis, metabolic liver disease)
3. Patients who have undergone bariatric surgery.
4. Pregnant woman, lactating woman, or a woman suspected of pregnancy.
5. Patients under insulin treatment.
6. Patients with severe cardiac disease.
7. Patients with severe kidney disease (CRE>2.0 mg/dL).
8. Patients who are unable to comply with administrative matters.
9. Patients who are allergic to the test foods.
10. Patients who have alcohol intake more than 30 g/day for male, and more than 20 g/day for female.
11. Patients who have participated in a clinical trials in the last 3 months.
12. Patients who are currently taking Misatol.
13. Patients who are judged by the investigator not to be appropriate for inclusion in the study.
120
1st name | |
Middle name | |
Last name | Mikio Zeniya |
Sanno Medical Center
Department of Internal Medicine
8-5-35, Akasaka, Minato-ku, Tokyo, 105-0003, Japan
03-3402-5581
zeniya@iuhw.ac.jp
1st name | |
Middle name | |
Last name | Shiro Ueda |
Medical Edge Inc.
Sytem Development
2-12-8, Shinjuku, Shinjuku-ku, Tokyo, 160-0022, Japan
03-4400-7070
system-info@medicaledge.jp
Sanno Medical Center
Otsuka Pharmaceutical Factory, Inc.
Profit organization
1.Jntenndo University Hospital
2.The Jikei University Daisan Hospital
3.Tokyo Metropolitan Bokutoh Hospital
4.Kyoundo Hospital
5. Chiba University Hospital
6.Kitaibaraki City Hospital
7.Shibata Hepatology Clinic
8.Toshima Hospital
NO
2017 | Year | 01 | Month | 15 | Day |
Unpublished
Completed
2016 | Year | 08 | Month | 18 | Day |
2016 | Year | 07 | Month | 25 | Day |
2017 | Year | 01 | Month | 12 | Day |
2019 | Year | 04 | Month | 30 | Day |
2019 | Year | 08 | Month | 22 | Day |
2019 | Year | 08 | Month | 22 | Day |
2020 | Year | 12 | Month | 09 | Day |
2017 | Year | 01 | Month | 15 | Day |
2020 | Year | 01 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027922
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |